KHAN, M. A. (2025) “QBD-DRIVEN DESIGN AND PHARMACOKINETIC PROFILING OF REMOGLIFLOZIN ETABONATE SUSTAINED-RELEASE MATRIX TABLETS FOR DIABETES MANAGEMENT”, International Journal of Applied Pharmaceutics, 18(1). doi: 10.22159/ijap.2026v18i1.56445.